{
    "nctId": "NCT01762020",
    "briefTitle": "Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation",
    "officialTitle": "Phase III Randomized Pair Comparison of a Barrier Film vs. Standard Skin Care in Preventing Radiation Dermatitis in Women With Breast Cancer Receiving Adjuvant Radiation Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Dermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 56,
    "primaryOutcomeMeasure": "Percent of patients developing modified Radiation Therapy Oncology Group(RTOG) Visual Assessment Score Grade II or greater radiation dermatitis induced by adjuvant radiation therapy in women with breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients between 18 and 80 years of age at the time of enrollment\n* Histopathologically or cytologically confirmed diagnosis of breast cancer\n* Completed lumpectomy and sentinel lymph node biopsy or axillary lymph node dissection\n* Signed and dated ethics-approved informed consent form prior to any study procedures\n* Ability to comply with the requirements of the study\n* Scheduled adjuvant radiation therapy treatment\n\nExclusion Criteria:\n\n* Clinical or radiological evidence of local recurrence or metastatic disease\n* Previous history of radiation therapy to ipsilateral axilla and/or breast area\n* Planned boost of radiation Dementia, psychoses, or other significant impairment of mental status that would prohibit the understanding and giving of informed consent or the participation in self-care or toxicity reporting\n* Any significant history or concurrent disease which, in the judgment of the Investigator would make the patient inappropriate for entry to this study\n* History of contraindications of radiation such as scleroderma",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}